Home / Inspections / 1102024

FDA Inspection 1102024 — Mary Bird Perkins Cancer Center

Mary Bird Perkins Cancer Center — FEI 3007686648

The FDA completed an inspection of Mary Bird Perkins Cancer Center on August 27, 2019 in Houma, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 27, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houma, LA (United States)

Facility

Other inspections at this facility

  • 1279775 (NAI Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1203081 (NAI Thu Apr 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 999716 (NAI Thu Feb 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 926021 (VAI Thu Apr 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 817164 (NAI Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources